Bruce Hsu, MD
Physical Medicine & Rehabilitation · Lancaster, PANPI 1932320876
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,921 of the $4,614 with a category attached, or 85.0%. 14 manufacturers reported payments, led by Medtronic at 35.1% of the total. Reporting peaked in 2019 at $2,243 and has fallen 94.6% since, to $122 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $58.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$1K
- Merz Pharmaceuticals, LLC$459
- Abbott$277
- Merz North America, Inc.$235
- Electronic Waveform Lab, Inc.$218
- plus $583 from 8 others
What the payments were for
- Travel & lodging$66314%
- Food & beverage$3,92185%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $1,618 |
| AbbVie(2 entities) | 29 | $1,223 |
| Merz Pharmaceuticals, LLC | 4 | $459 |
| Abbott | 4 | $277 |
| Merz North America, Inc. | 5 | $235 |
| Electronic Waveform Lab, Inc. | 5 | $218 |
| Novartis | 2 | $172 |
| Genentech USA, Inc. | 1 | $146 |
| Biogen | 2 | $121 |
| Avanir Pharmaceuticals, Inc. | 1 | $84 |
| Akorn, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIORESAL$841
- BOTOX$457
- XEOMIN$385
- UBRELVY$372
- OCREVUS$146
- Proclaim IPG$146
- INTELLIS$123
- SYNCHROMED$110
- GILENYA$107
How this compares
$4,614 in reported general payments places this provider in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 22 | $129 |
| Tramadol Hcl | 21 | $41 |
| Cyclobenzaprine Hcl | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Lancaster
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
- Alberto EsquenaziPhiladelphia$305K
- Mitchell PaulinPaoli$229K
- Kimberly HeckertPhiladelphia$119K
- David LichtenReading$117K
- Gay WilcherRidley Park$81K
- Jessica MulhernPaoli$79K
- Leonard KamenElkins Park$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.